Background/Aims: Patients with hepatitis B virus (HBV) infection are at a high risk of developing hepatocellular carcinoma (HCC). In this study, we aim to investigate the roles of HBV on angiogenin (ANG), as well as the effects on cell proliferation in presence of ANG down-regulation. Methods: Serum ANG was determined by ELISA. The expression of ANG mRNA and protein in HCC cell lines with or without HBV/HBx were determined. Western blot and ELISA were conducted to determine the effects of HBV/HBx on IL-6 expression. The role of IL-6 on ANG was evaluated by IL-6 recombinant protein or IL-6 neutralizing antibody. Immunofluorescence staining was used to detect the nuclear translocation of ANG. MTT was performed to evaluate the relative inhibition ratio. Result: In vivo experiments showed elevation of serum ANG in patients infected with HBV. In vitro experiments showed HBV and HBx contributed to the transcription and translation of ANG. ANG expression showed increase after IL-6 stimulation, and ANG protein decreased in the presence of IL-6 blocking with its antibody. HBV promoted nuclear translocation of ANG. Inhibiting ANG expression or blocking of nuclear transfer of ANG attenuated the 45S rRNA synthesis and cell proliferation. Conclusion: HBV and HBx protein can increase the level of ANG through IL-6. HBV and HBx contributed to the nuclear translocation of ANG. Cell proliferation was inhibited after inhibiting the expression or nuclear transfer of ANG.
Introduction
Hepatitis B virus (HBV) infection is a worldwide health problem [1] affecting about 240 million persons until 2005 [2] . Although HBV infection rate has been significantly reduced with the utilization of vaccines, HBV-related mortality is severe worldwide as up to 1 million people died from chronic HBV-related complications [3] , such as chronic hepatitis, cirrhosis, Prof. Zhi Chen and Prof. Shuping Li acute liver failure (ACLF), and particularly hepatocellular carcinoma (HCC) [4] . Nowadays, the majority of HCC (up to 75%), considered as one of the most common malignancies among human cancers [5, 6] , is caused by chronic HBV or HCV infection [7] . Since the first report on the relation between HBV and HCC in 1970 [8] , extensive aspects have been considered to be responsible for the HBV-induced HCC, including genetic damages by immune-mediated hepatic inflammation, oxidative stress, a virus-specific mechanism involving the viral proteins HBV X (HBx) and HBs, as well as the insertional mutagenesis with integration of HBV DNA into the host genome [9] . Among them, HBx protein is thought to be the most crucial factor in hepatocarcinogenesis [10, 11] , and has been reported to be closely related to the pathogenesis of HCC by modulating several cell signaling pathways, such as p53, PI3K/ AKT, and NF-κB pathways [12, 13] . In addition, it can also affect the expression of miR-21 [14] , miR-18a [15] , miR-145 [16] , and miR-122 [17] .
Angiogenin (ANG), a 14 kDa protein consisted of 123 amino acids, is the fifth member of ribonuclease A superfamily (RNASE5) [18] . To date, it has been proved to be upregulated in many human cancers such as prostate cancer [19] , breast cancer [20] , colorectal cancer [21] , gastric cancer [22] , brain tumor [23] , lung cancer [24] , and liver cancer [25] . It was reported to involve in several biological processes such as rRNA production [26] , tiRNA production in the presence of stress [27] , as well as cancer cell proliferation [28] . In a previous study, Sadagopan et al. reported that Kaposi's sarcoma associated herpesvirus (KSHV) involved in up-regulation of ANG, which then contributed to the ANG-induced 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, angiogenesis, and finally promoted tumorigenesis [29] . Additionally, EDN and ECP (two members of ribonuclease A superfamily) showed negative effects on RSV [30] , among which EDN could also protect against HIV-1 infection [31] . These findings lead us to investigate the relationship between ANG and HBV-related HCC.
In this study, we determined the serum ANG expression in HBV-infected patients and healthy controls. On this basis, the mechanism of ANG up-regulation mediated by HBV and its effects on cell proliferation were further elucidated by in vitro experiments.
Materials and Methods

Sample collection
Specimens were obtained from 140 participants presented to the First Affiliated Hospital of Zhejiang University from March 2010 to April 2011 including health controls (n=32) recruited from health examinations with hepatitis, asymptomatic carriers (ASC) of HBV (n=38), patients with mild chronic hepatitis B infection (CHB-M) (n=38), as well as patients with severe chronic hepatitis B infection (CHB-S) (n=32). Venous blood samples (2 mL) were collected from each participant and then serum was obtained after centrifugation at 3, 000 rpm for 15 min. Subsequently, the supernatant was collected, followed by centrifugation at 12, 000 rpm for 5 min. All serum samples were stored at −80 °C. Each participant signed the informed consent. The study protocols were approved by the Ethical Committee of First Affiliated Hospital of Zhejiang University.
Regents and Antibodies
Serum and supernatants ANG were tested by Human Angiogenin ELISA Kit (DAN00, R&D, USA). Neomycin (N6386) and paromomycin (P9297) were purchased from Sigma-Aldrich (Sigma, USA). Recombinant Human IL-6 protein (7270-IL-025/CF) were bought from R&D (CA, USA). The siRNA for silencing ANG (sc39291) and control siRNA (sc37007) were purchased from Santa Cruz (MI, USA). The antibodies used in this study were as follows: Mouse anti-angiogenin (1:500 dilution, ab10600, Abcam, USA), rabbit anti-IL6 (1:500, ab6672, Abcam, USA), rabbit anti-histone H3 (1:2000, #4620, Cell Signaling Technology, USA) and mouse anti-β-actin (1:3000 , 4970, Cell Signaling Technology, USA). 
RNA interference assay
HepG2 cells were seeded on 24-well plates and incubated overnight. Then the cells were treated using ANG-specific small interfering RNA and control siRNA, respectively. A concentration of 50nM was selected for Lipofectamine RNA imax (Invitrogen, USA). Cells were harvested 48 hrs after transfection for further analysis.
Real-Time PCR analysis
Total RNA was extracted from HCC cells using Trizol reagent (Takara, Japan) according to the manufacturer's instructions. The cDNA synthesis was performed using 1 µg total RNA using PrimeScript RT reagent Kit (Takara, Japan). Real-Time PCR was used for the amplification using SYBR Premix (RD, USA) according to the manufacturer's instructions. The amplification conditions included denaturation at 95 °C for 2 min, followed by 40 cycles of 95 °C for 15 sec and 62 °C for 60 sec. The mRNA level was normalized by GAPDH. The relative expression level was determined according to the 2 -ΔΔCt method. The specific primers used in the proliferation was listed as follows:
Immunofluorescence assay Cells (2×10 4 ) were seeded on glass coverslips in 24-well plates. About 48 hrs later, the cells were washed with cold PBS twice, and then fixed with pre-cold methanol at -20°C for 10 min. After washing with PBS twice, the mixture was blocked in PBS containing 30 mg/ml BSA at 37°C for 10 min twice. Subsequently, the mixture was incubated with 26-2F (ANG antibody, made in house, 30 μg/ml) in PBS containing 5 mg/ml of BSA at 4°C overnight. After incubating with Alex 488 anti-mouse antibody (1: 500, A11001, Invitrogen, USA) in PBS containing BSA (5 mg/ml) at 37°C for 1 hr, the mixture was washed with PBS containing BSA (5 mg/ml) at 37°C for 10 min for 5 times. Afterwards, nuclear staining dye TO-PRO®-3 (1: 300, S33025, Invitrogen, USA) was added, and then incubated for 15 minutes at room temperature. Finally, the images were observed under a confocal microscopy (Olympus Inc, Center Valley, PA, USA).
Western blot analysis HCC cells were lysed with 50 µL RIPA for 10 min on ice. The cell lysates were centrifuged at 12, 000 g at 4°C. Nucleoprotein were extract from HepG2.215 cells using nuclear and cytoplasmic extraction reagents (78833, ThermoFisher Scientific, CA, USA). Protein (50 μg) was separated by SDS-PAGE and then transferred to PVDF membranes (Bio-Rad, USA). The membranes were incubated with the antibodies overnight at 4°C after being blocked with 5% non-fat milk for 1 hr. The membranes were washed with 1×TBS-Tween 3 times and incubated with secondary antibodies at room temperature for 2 hrs. Protein was analyzed with chemiluminescent detection. The relative expression of ANG and IL-6 was normalized by β-actin, and the relative expression of ANG nucleoprotein was normalized by histone H3.
MTT assays
To further confirm the effects of ANG on HepG2.2.15 or HepG2, cells were seeded on a 96-well plate at a density of 3×10 4 per well. The attached cells were pretreated with neomycin/paromomycin, IL-6/IL-6 Ab or ANG siRNA, and then were subject to MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay. Then 10 µl MTT reagent (Millipore, Billerica, MA, USA) was added to each well. After incubating for 4 hrs, cells were lysed by adding 200 µL DMSO. Absorbance was measured at a wavelength of 570 nm. 
Statistical analysis
All data were analyzed with SPSS version 16.0. Data were presented as mean±standard deviation (SD). Each experiment was repeated at least three times. The differences between two groups were compared using Student's t-test. P<0.05 was considered to be statistical significance.
Results
The serum ANG increased in patients infected by HBV As shown in Table 1 , no significant difference was observed in age and gender ratio among three groups. Serum ANG was measured by ELISA. As shown in Fig. 1 , serum ANG showed significant increase in ASC and CHB-M groups compared to that of healthy controls. In contrast, no statistical difference was noticed in serum ANG among ASC, CHB-M and CHB-S patients. These indicated that HBV infection might contribute to the elevation of serum ANG. Fig. 2E and 2F) .
HBx promoted the expression of ANG in HepG2
To identify the putative composition of HBV that increased the ANG level, HepG2 and Huh7 cells were transfected with pcDNA3.1-EGFP-HBx. Fig. 3 showed the ANG mRNA and protein levels were up-regulated after transfection. This suggested that HBx may involve in mediating the HBV-induced ANG uptake.
HBV/HBx increased ANG through raising the level of IL-6
To further investigate how HBV/ HBx involved in the regulation of ANG, we measured the IL-6 protein. IL-6 expression was upregulated in HepG2.2.15 cells or HepG2 cells transfected with HBx plasmid (Fig. 4A and 4B) . Furthermore, IL-6 (50ng/ ml) contributed to the up-regulation of both ANG mRNA and protein in these cells (Fig.  4C-4F) . Conversely, when treating with IL-6 neutralizing antibody (1:400) for 48 hrs, the ANG level in HepG2.2.15 cells was reduced ( Fig. 4G and 4H ). These results suggested that up-regulation of ANG by HBV/HBx may be associated with elevation of IL-6. 
HBV/HBx contributed to nuclear transfer of ANG
The biological activity of ANG depends on its nuclear transfer. During the normal life cycle, the process of ANG nuclear transfer is under subtle regulation, and this process will decrease with the increase of cell density. In order to explore the biological roles of the high-expressed ANG induced by HBV, subcellular localization of ANG protein was monitored by confocal microscopy. Our data showed that nuclear transfer of ANG in 2215 cells or HepG2-HBx was significantly higher than that in HepG2 cells. Whereas, nuclear transfer of ANG in HepG2 cells showed no statistical difference in the presence of IL-6 (Fig. 5) .
Inhibition
of ANG can decrease cell proliferation R i b o s o m e transcription is the basis of cell proliferation regulation. Previous study confirmed that nuclear ANG-promoted ribosome transcription was mainly responsible for ANG-induced prostate cancer development [32] . To investigate the effects of ANG on the synthesis of rRNA in hepatocytes, Real-Time PCR was used to detect the expression of ribosomal 45S rRNA in HepG2.2.15 cells treated with exogenous ANG (1μg/ml) or ANG siRNA in this study. The results confirmed that ANG could promote the synthesis of 45S rRNA in HCC cells, and inhibition of ANG expression can also inhibit the synthesis of 45S rRNA (Fig. 6A) . Similarly, HBx and IL-6 also contributed to 45S rRNA expression (Fig. 6B and  6C) . Meanwhile, the proliferation of liver cells treated by ANG siRNA was inhibited (Fig. 7A  and 7B ). When treated with neomycin (200 μM), an inhibitor of ANG nuclear translocation [33] , the proliferation of liver cells can be inhibited, while paromomycin serving as a control of neomycin [34] can not inhibit the proliferation (Fig. 7D and 7E) . Also, inhibition of IL-6 could attenuate the proliferation of HCC cells (Fig. 7 F and 7G ).
Discussion
ANG, up-regulated in many human cancers [28] , can promote tumor angiogenesis and stimulate tumor cells proliferation directly by stimulating the expression of NF-κB and Bcl- 35] , or promoting rRNA transcription [36] . It is initially identified as an angiogenesis factor, and recently, more attention has been paid on its role of angiogenesis in chronic inflammation during tumorigenesis. In this study, we investigate the regulatory roles of HBV on ANG. Our data showed that HBV/HBx could up-regulate ANG via IL-6, which contributed to the proliferation of tumor cells. Hepatitis B has been found strongly to be associated with HCC, especially in developing countries [37] . In order to investigate the effects of HBV on ANG, we measured the ANG level in HBV-infected patients. Our data suggested that ANG was up-regulated after HBV infection compared to healthy controls. Additionally, HepG2.2.15 cell, a HCC cell line stably expressing HBV virus particles was used to test ANG mRNA and protein.
In vitro experiments confirmed that HBV could also promote the expression of ANG. High ANG expression has been reported to be associated with the pathogenesis of HCC. On one hand, extracellular ANG can activate hepatic stellate cells [38] . On the other hand, nuclear ANG involved in the ribosomal RNA transcription [28] . In this study, our findings may reveal a new mechanism for HBV carcinogenesis through modulating the expression of ANG in vivo.
Several factors were associated with the pathogenesis of HBV-induced HCC, such as the integration of HBV virus into the host genome, activation of host proto-oncogene by HBV, or the interaction of host protein and the protein of HBV (e.g. core protein, pre-S protein and X protein) [39] . Among these factors, HBx is of much concern due to its active carcinogenic effects. Here, we demonstrated that HBx contributed to the elevation of ANG, which further confirmed the up-regulatory effects of HBV on ANG.
Inflammatory factors secreted by macrophages and lymphocytes in the tumor immune microenvironment may serve as an important regulator in innate immunity, allowing tumor cells to exert anti-apoptotic and angiogenic effects [40] . As a potent pleiotropic inflammatory cytokine, IL-6 has been shown to play an important role in the pathogenesis of liver cancer, including stimulating cell proliferation and hepatic remodeling. Additionally, it also plays an important role in the survival of patients received hepatectomy [40] [41] [42] . IL-6 is usually elevated in those infected HBV, and is closely related to the pathogenesis of HCC [43] . Moreover, it was reported to involve in the up-regulation of both ANG mRNA and protein [44] . These findings suggested that HBV may contribute to the expression of ANG through modulating the IL-6 activity. Thus, we measured the IL-6 level in both HepG2 cells and HepG2.2.15 cells, which indicated that the ANG mRNA and protein levels were up-regulated to some extent. In contrast, the ANG expression was down-regulated after neutralizing its activity with antibody. These results suggested the effects of IL-6, mediated by HBV, were [45, 46] . Simultaneously, ANG can activate NF-κB pathway to inhibit apoptosis [35] . Therefore, we hypothesize that the up-regulation of ANG may promote tumor cell proliferation by positive feedback of NF-κB/IL-6 pathway. The roles of ANG in cells are highly depending on its location. In cytoplasm, ANG acts as a RNase cleaving tRNA and producing tRNA-halves, which has been reported to be reduced in liver cancer [47] . In nucleus, ANG is involved in up-regulating rRNA expression [36] or promoting angiogenesis [48] , which then stimulates tumor cell proliferation. Under normal conditions, the nuclear translocation of ANG is well regulated. Its nuclear translocation was reported to be reduced in the presence of increased cell density. On this basis, rRNA was kept in balance, in order to guarantee the physiological activities of cells [36] . By subcellular localization of ANG protein, we found that HBV could promote ANG nuclear translocation. Moreover, nuclear ANG could promote 45S rRNA in HepG2.2.15 cells, while increased rRNA transcription might induce aberrant cell proliferation. As high level ANG can promote rRNA transcription and cell proliferation [26] , we hypothesize that some strategies may be developed to reduce cell proliferation of HCC cells by inhibiting ANG. To our expectation, 45S rRNA transcription decreased in presence of inhibiting ANG expression using siRNA technique, and cell growth were inhibited at the same time. Similarly, the cellular proliferation was reduced when using neomycine to inhibit the ANG nuclear translocation. These findings suggest that ANG inhibitors may be a promising candidate for treating HBV related HCC.
In summary, we firstly reported that HBV upregulated ANG expression by modulatingIL-6 expression and ANG nuclear translocation. The cellular proliferation of HCC cells was inhibited in the presence of ANG down-regulation or its nuclear translocation in HBV infected HCC cells. These findings may give a new way to the research and development of drugs for treating HBV related HCC.
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